WHO releases emergency use validation for Pfizer’s vaccine, BioNTech COVID-19



ANI |
Update:
01 Jan 2021 04:11 STI

Geneva [Switzerland], January 1 (ANI / Sputnik): The World Health Organization announced on Thursday that it has published an emergency use validation of the vaccine against the coronavirus developed by the companies Pfizer and BioNTech, the first since the start of the pandemic .
The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer / BioNTech vaccine the first to receive emergency validation from the WHO since the start of the epidemic a year ago, “the WHO said in a statement. .

The WHO decision has enabled UNICEF and the Pan American Health Organization to procure the vaccine for distribution to countries in need.
“WHO and our partners are working around the clock to evaluate other vaccines that have met standards for safety and efficacy. We are encouraging even more developers to come forward for review and evaluation. It is vitally important that we secure the essential supply needed to serve all countries. world and stem the pandemic, ”said Mariangela Simao, WHO Assistant Director-General for Access to Medicines and Health Products.
The WHO declared the COVID-19 outbreak a pandemic on March 11. To date, more than 83.1 million people have been infected with the coronavirus worldwide, with more than 1.81 million dead, according to Johns Hopkins University. (ANI / Sputnik)

Source